Taken together, our data support the hypothesis that SKP2 plays an essential role in OS tumorigenesis and suggest that cancers with combined alterations of Rb1 and TP53, such as OS, are particularly vulnerable to SCFSKP2 inhibition. The gene discussed is RB1; the disease is cancer.